LUMBAGO: ENHANCING THE EFFICIENCY OF THERAPY

Abstract

Lumbago is an exceptionally common syndrome associated with sizable material costs, high recurrence incidence rates, and a risk for chronic pain. While managing a patient with lumbago, it is necessary to exclude the potential causes of secondary pain syndrome, including injuries, neoplasms, local infections, and somatic diseases. Nonsteroidal anti-inflammatory drugs and analgesics, which are responsible for side effects in a number of cases, have a good analgesic effect. Concurrently with their use, Milgamma, a neutropic vitamin B complex, produces a higher antinociceptive effect, a less need for analgesic drugs, shorter treatment, and more prolonged remission.

Keywords

• lumbago
• discogenic radiculopathy
• nonsteroidal anti-inflammatory drugs
• B-group vitamins
• Milgamma